MECR Knockout HEK293T Cell Line
Cat.No.:
EDC08075
Species:
Human
Cell Name:
HEK293T
Gene:
MECR
Gene ID:
51102
Size:
1×10⁶cells
MECR Knockout HEK293T Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08075 |
|---|---|
| Product Name | MECR Knockout HEK293T Cell Line |
| Species | Human |
| Cell Line | HEK293T |
| Cellosaurus ID | CVCL_0063 |
| Gene ID | |
| Cell Line Synonyms | Hek293T, HEK-293T, HEK 293T, HEK-293-T, HEK 293 T, 293-T, 293 T, 293T, Human Embryonic Kidney 293T, 293tsA1609neo |
| Gene | MECR |
| Summary |
The protein encoded by this gene is an oxidoreductase that catalyzes the last step in mitochondrial fatty acid synthesis. Defects in this gene are a cause of childhood-onset dystonia and optic atrophy. [provided by RefSeq, Mar 2017]
|
| Associated Diseases | Non-tumor |
| Digestion Time | 30 sec~1 min |
| Morphology | Adherent |
| Passage Ratio | 1:5 |
| Complete Culture Medium | DMEM+10% FBS+1% NEAA+1% GlutaMax |
| Freezing Medium | 95% complete culture medium + 5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293T | STR Info (Cell bank) Cell Line: HEK293T | ||||
| Allele1 | Allele2 | Allele3 | Allele1 | Allele2 | Allele3 | |
| Amelogenin | X | X | ||||
| CSF1PO | 11 | 12 | 11 | 12 | ||
| D2S1338 | 19 | 19 | ||||
| D3S1358 | 15 | 16 | 17 | 15 | 16 | 17 |
| D5S818 | 8 | 9 | 8 | 9 | ||
| D7S820 | 11 | 11 | ||||
| D8S1179 | 11 | 12 | 14 | 12 | 14 | |
| D13S317 | 12 | 14 | 12 | 14 | ||
| D16S539 | 9 | 13 | 9 | 13 | ||
| D18S51 | 17 | 18 | 17 | 18 | ||
| D19S433 | 18 | 18 | ||||
| D21S11 | 28 | 30.2 | 28 | 30.2 | ||
| FGA | 23 | 23 | ||||
| Penta D | 9 | 10 | 9 | 10 | ||
| Penta E | 7 | 15 | 7 | 15 | ||
| TH01 | 7 | 9.3 | 7 | 9.3 | ||
| TPOX | 11 | 11 | ||||
| vWA | 16 | 19 | 16 | 19 | ||
| D6S1043 | 11 | |||||
| D12S391 | 19 | 21 | 19 | 21 | ||
| D2S441 | 11 | 15 | 11 | 15 | ||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying MECR function, MECR Knockout HEK293T Cell Line or MECR overexpression HEK293T Cell Line?
The choice depends on whether you are studying MECR (mitochondrial trans-2-enoyl-CoA reductase)'s role as the terminal enzyme of mitochondrial fatty acid synthesis II (mtFASII) or modeling MEPAN (MECR-associated neurodegeneration) syndrome. The Knockout line is the standard tool for asking whether MECR is required for these processes — MECR catalyzes the NADPH-dependent reduction of mitochondrial trans-2-enoyl-ACP intermediates during de novo fatty acid synthesis within mitochondria, distinct from the cytosolic FAS pathway. mtFASII generates octanoyl-ACP, the substrate for lipoic acid synthesis (essential for PDC, KGDH, BCKDH function). Overexpression is useful for studying MECR in heterologous expression contexts.
For mitochondrial metabolism research, the EDITGENE MECR Knockout in HEK293T is highly informative — HEK293T's very high transfection efficiency supports systematic structure-function studies. MECR biallelic loss-of-function mutations cause MEPAN (autosomal recessive childhood-onset dystonia with optic atrophy and basal ganglia abnormalities, with bilateral basal ganglia degeneration on MRI) — disease variant rescue enables genotype-function studies. Rescue with wild-type or catalytically-dead MECR enables comprehensive structure-function studies. The knockout is valuable for studying lipoic acid biosynthesis, PDC/KGDH lipoylation, and emerging mtFASII-related therapeutic strategies.
What are the application scenarios for this model?
Primary applications:
• Lipoic acid biosynthesis: lipoylation status of PDC (PDHA1), KGDH (DLST), BCKDH (DBT), and GCS (GCSH) E2/H components by anti-lipoyl Western blot — mtFASII loss reduces lipoylation.
• Mitochondrial bioenergetics: Seahorse OCR/ECAR analysis given mtFASII's contribution to mitochondrial complex function via lipoylation.
• MEPAN modeling: rescue with patient-derived MECR mutations for genotype-function correlation studies of MECR-associated neurodegeneration.
• mtFASII pathway analysis: ACP (mt-ACP) acyl chain composition by mass spectrometry to characterize mtFASII flux in the absence of MECR.
EDITGENE recommends this model for researchers investigating mitochondrial fatty acid synthesis, lipoic acid biology, MEPAN disease mechanisms, and mtFASII-related metabolic disease.
Is this MECR Knockout HEK293T Cell Line compatible with overexpression rescue experiments?
Yes. MECR rescue experiments require attention to mitochondrial targeting:
• Construct design: use a codon-modified MECR sequence with a small C-terminal tag (FLAG, HA). MECR has N-terminal mitochondrial targeting sequence cleaved upon import — N-terminal tags must not disrupt processing.
• Mitochondrial localization validation: confirm mitochondrial matrix localization by appropriate compartment markers.
• Catalytically-dead rescue: NADPH-binding or substrate-binding pocket mutations abolish enoyl-CoA reductase activity and serve as the standard specificity control.
• MEPAN mutation rescue: patient-derived MECR mutations enable disease genotype-function studies.
• Functional readout: rescue should restore PDC/KGDH/BCKDH lipoylation status (anti-lipoyl Western blot) and mitochondrial respiration as functional outputs of restored mtFASII.
HEK293T transduces with very high efficiency and supports systematic structure-function rescue experiments.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download